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Unsafe abortionThe Obstetrical and Gynaecological Society of Bangladesh was an important advocate in mobilizing government
authorities to adopt new techniques for postabortion care and provide long-acting contraceptives post abortion.
With the support of the International Federation of Gynecology and Obstetrics (FIGO), the Society provided com-
modities and training to increase the use of these techniques in 7 private and public hospitals and clinics. Data
from two of these institutes for the January 2012 to June 2013 period showed a rapid decrease in the use of dila-
tion and curettage, an increase in the use of manual vacuum aspiration (MVA) andmisoprostol, and the progres-
sive adoption of long-acting reversible contraceptives, permanent contraception, and injectable contraceptives in
one of these two hospitals. The Directorates General of Health and Family Planning incorporated training in the
use of MVA and misoprostol in their national operation plans. The success in these hospitals shows that the pro-
posed changes have been well accepted by providers and clients.
© 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd.
Open access under CC BY-NC-ND license.1. Introduction
In Bangladesh,maternalmortality resulting from abortion complica-
tions has fallen signiﬁcantly from 13% of all maternal mortality in 2001
to less than 1% in 2010 [1,2]. However, the number of abortions still re-
mains considerably high, ranging from 523 803 to 769 269, with an
estimated 280 000 women having been treated for complications of ei-
ther spontaneous or induced abortion in 2010 [3,4]. This imposes a pre-
ventable burden on the health system [3]. Overall, 61% of married
Bangladeshi women aged 15–49 years are currently using a contracep-
tive method and the total fertility rate is 2.3 children per woman; how-
ever, 15% of births are mistimed and 13% are unwanted [5].
In 2008, the International Federation of Gynecology and Obstetrics
(FIGO) launched the FIGO Initiative for the Prevention of Unsafe Abor-
tion and its Consequences, the goal of which was to reduce themorbid-
ity and mortality resulting from unsafe abortions and to reduce the
burden of unsafe abortion on women and the public health system
[6–8].pur, Dhaka 1207, Bangladesh.
and Obstetrics. Published by Elsevier IBangladesh is one of the countries in South-Southeast Asia partici-
pating in the initiative. Over the years, its plans of action have included
advocacy with policymakers; raising awareness among health profes-
sionals; counseling adolescents on sexual and reproductive health;
developing/updating manuals and guidelines; producing information,
education, and communication (IEC) materials on postabortion care,
manual vacuum aspiration (MVA), and medical menstrual regulation;
training healthcare providers in the MVA technique, in the use of miso-
prostol for the treatment of incomplete abortion, and in postabortion
contraception; providing MVA kits and misoprostol; and encouraging
the use of these techniques in selected hospitals. Bangladesh’s current
plan of action involves the following two objectives:
(1) To provide postabortion care withMVA ormisoprostol to at least
80% of women admitted with or consulting for incomplete abor-
tion in 7 selected hospitals and clinics supported by the Obstetri-
cal and Gynaecological Society of Bangladesh (OGSB) by
December 2013, with the expectation of reaching close to 100%
by December 2014;
(2) To provide postabortion contraceptives to at least 60% of women
seeking care for incomplete abortion or menstrual regulation/
menstrual regulation with medication (MR/MRM) in 7 selected
OGSB-supported hospitals and clinics, and to ensure that atreland Ltd. Open access under CC BY-NC-ND license.
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ceptive (LARC) method.
According to the perceptions of health professionals participating in
a 2010 survey, the great majority of healthcare facilities capable of pro-
viding postabortion care actually do provide these services, with only
16% of facilities failing to provide them [3,4]. However, although post-
abortion care guidelines recommend that family planning services be
provided to all patients, the ﬁndings revealed large gaps in the extent
towhich providers compliedwith this recommendation. Only 34% of fa-
cilities offered contraceptivemethods to postabortion care patients, and
fewer than half of these women actually received a method [3]. The
above-mentioned objectives were designed to improve this situation,
beginning with a group of hospitals in which the OGSB is able to inﬂu-
ence the provision of care.
The present paper provides a background of MVA and misoprostol
use for the treatment of incomplete abortion in Bangladesh, highlight-
ing the work performed under the FIGO initiative, and evaluates the
progress achieved in replacinguterine curettagewithMVAormisopros-
tol, and in promoting the acceptance of postabortion LARC methods.
2. MVA for the treatment of incomplete abortion
MVA is a safe, effective technique for uterine evacuation. Both the
World Health Organization (WHO) and FIGO recommend MVA as the
method of choice for uterine evacuation in cases of incomplete abortion
and induced abortion in early pregnancy [9,10].
Box 1 provides a summary of the use of MVA in Bangladesh. Ofﬁcial-
ly introduced in 1979 to provide services of menstrual regulation (MR),
theMVA/MR syringeswere often used for uterine evacuation in cases of
incomplete and missed abortions. In 2002, the Directorate General of
Family Planning introduced the concept of postabortion care services
and the use of the double-valve MVA syringe for uterine evacuation
(as long as uterine volume was less than that of a 12-week pregnancy)
in cases of incomplete and missed abortion. Doctors at selected mater-
nal and child welfare clinics, which functioned under the Directorate
General of Family Planning, and NGO clinics (the Rising Sun Franchise)
were initially trained to provide postabortion care services using MVA
instead of dilation and curettage (D&C). These facilities, however, main-
ly provided prenatal,delivery and post natal care; and family planning
services, with only very limited postabortion care services. Comprehen-
sive postabortion care services were provided in upazila (subdistrict)
health complexes, district hospitals, and in university teaching hospitals
where, paradoxically, D&C was the technique used, since MVA equip-
ments was not available and doctors were not trained in the use of
that procedure. This situation was improved, and a training curriculum,
guidelines, and technical standards for postabortion care, including aBox 1
Increasing the use of manual vacuum aspiration (MVA) for cases of incomp
1979 MVA technique officially introduced for menstrual regulati
2002 The DGFP introduced postabortion care services including
MCWCs and NGO facilitiesa
2007 The OGSB disseminated the FIGO statement on the use of
2008 OGSB joined the FIGO Initiative for the Prevention of Unsa
of Health Services and Family Planning), and several NGOs
2009 A policy brief was developed on the prevention of unsafe a
2010 MVA was approved for postabortion care by the DGHS
2011 FIGO funding for the procurement of Ipas MVA plus aspira
2012−13 Training on the use of MVA for postabortion care was give
2012−13 Services were provided to postabortion care clients (MVA
postabortion family planning counseling and services)
Abbreviations: DGFP, Directorate General of Family Planning; MCWC, Mother and Child Wel
torate General of Health Services.
a Rising Sun Franchise.manual in the Bengali language, were developed in 2002 and updated
in 2010.
In 2007, to popularize the use of MVA for postabortion care services,
the OGSB issued the following statement: “In line with the recommen-
dation of FIGO, the WHO and other professional bodies, the Obstetrical
and Gynecological Society of Bangladesh (OGSB) acknowledges the
use of MVA/MVA plus as a safer alternative to dilatation and curettage
for postabortion care” [11].
A number of clinical meetings/seminars were conducted by the
OGSB to familiarize obstetricians and gynecologists with MVA as a
method of uterine evacuation. However, only relatively few clinicians
performed this procedure. The following barriers to its adoption were
identiﬁed:
(1) Lack of training
The health service providers working in facilities where women
with abortions were admitted for treatment received inadequate in-
service training on comprehensive postabortion care services or in the
use of MVA (particularly the double-valve syringes). These facilities,
which functioned under the Directorate General of Health Services
(DGHS), included university teaching hospitals/ medical college hospi-
tals, district hospitals, and Upazila health complexes.
(2) Lack of equipment
The MR (single-valve Karman’s syringe) and Ipas MVA plus aspira-
tors [12]were not supplied to university teaching hospitals, district hos-
pitals, or medical institutes. They were procured by the Directorate
General of Family Planning but not by the Directorate General of Health
Services.
After the introduction of the FIGO initiative, a joint plan of actionwas
developed by the OGSB, the government of Bangladesh (the Director-
ates General of Health Services and of Family Planning), and national
and international organizations. Under this plan, the OGSB developed
a policy guide for the policymakers on different strategies for reducing
the incidence and consequences of unsafe abortion, with an emphasis
on training healthcare professionals in MVA for uterine evacuation,
organizing the provision of services, obtaining MVA instruments, and
supervising and monitoring these services. Later, during the develop-
ment of the 5-year plan under the national “Health, Nutrition and Pop-
ulation Sector Planning” and its operation plan, the OGSB interacted
with policymakers and successfully introduced postabortion care (in-
cluding the procurement of the necessary equipment and the training
of healthcare professionals) as a component of maternal healthcare in
2010. Later, in 2011, the Directorate General of Health Services issued
a letter allowing the OGSB to train professionals in the use of MVA
and misoprostol for postabortion care in selected health facilities.lete abortion in Bangladesh.
on services
double-valve MVA for use in cases of incomplete abortion in selected
MVA for cases of incomplete abortion
fe Abortion, and involved government organizations (the Directorates
bortion and advocacy was conducted with the policymakers
tor and cannulas
n to service providers and equipment was procured
for uterine evacuation, misoprostol in postabortion care, and
fare Centers; OGSB, Obstetrical and Gynaecological Society of Bangladesh; DGHS, Direc-
Box 2
Introduction of misoprostol for cases of incomplete and missed abortion.
2010 Dissemination of the IJGO Supplement on the use of misoprostol in cases of incomplete abortion
2010 Approval of misoprostol in postabortion care by the National Technical Committee, and its inclusion for the management of i
ncomplete and missed abortions in the updated DGFP postabortion care guidelines/technical standards
2011 Approval by DGHS of the use of misoprostol in postabortion care for training and services
2012 The OGSB developed guidelines and a protocol on misoprostol for postabortion care
2012−13 The OGSB provided training in postabortion care, including the use of MVA and misoprostol in cases of incomplete abortion
and of postabortion contraception, with an emphasis on the use of long-term methods
2012−13 The OGSB developed information, education, and communication (IEC) material on misoprostol in postabortion care
2012−13 Provision of services by trained services providers, including postabortion contraception
Abbreviations: IJGO, International Journal of Gynecology and Obstetrics; DGFP, Directorate General of Family Planning; DGHS, Directorate General of Health Services; OGSB, Obstet-
rical and Gynaecological Society of Bangladesh.
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the OGSB. The society used these resources to purchase MVA aspirators
and cannulas, which were provided to participating hospitals and
clinics. This funding was also used to train a limited number of health
service providers. The amount of time required to procure the equip-
ment and the political situation in the country resulted in a delay in ini-
tiating training. In the meantime, under an initiative adopted by the
Population Council and later by Ipas, the OGSB, and other stakeholders,
and following reports of the successful and safe use of MVA by non-
physicians [13,14], the government approved the training of nurses
and paramedics in the use of MVA for incomplete abortion in selected
cases and allowed them to deliver this service [15]. This task shifting
was intended to make these services available at peripheral level facili-
ties including Union Health and Family Welfare Centers in rural areas.
At the present time, 44 providers, including 28 doctors and 16 nurses/
paramedics from selected public and private sector facilities have been
trained.
3. Misoprostol in cases of incomplete abortion
The use of misoprostol for the management of incomplete abortion
in womenwith a uterine size no larger than that of a 12-week pregnan-
cywas approved by theDirectorate General of Family Planning after De-
cember 2010 when the OGSB circulated a supplement published in the
International Journal of Gynecology andObstetrics on the use ofmisopros-
tol in obstetrics and gynecology [16,17]. The use ofmisoprostol was also
included in the “postabortion care guidelines and technical standards”
of the Directorate General of Family Planning, which were updated at
that time. The Directorate General of Health Services authorized the
use of misoprostol in postabortion care and approved training by the
OGSB (2011). The OGSB developed guidelines and a protocol “Miso-
prostol in Postabortion Care” (Box 2), which is now a part of postabor-
tion training in Bangladesh [18].
4. Postabortion contraception
In 2009, a consensus statement on family planning after abortion
was issued by FIGO, the International Confederation of Midwives
(ICM), the International Council of Nurses (ICN), the United StatesTable 1
Number of abortion cases treated with dilatation and curettage (D&C), manual vacuum aspira






January – June, 2012 74.5 89.4 23.5
July – December, 2012 45.3 82.6 46.9
January – June, 2013 1.3 60.6 85.3Agency for International Development (USAID), the White Ribbon Alli-
ance (WRA), the Department for International Development (DFID),
and the Bill andMelinda Gates Foundation [19]. Following this, counsel-
ing on family planning and the provision of postabortion contraceptive
methods, particularly the use of long-acting reversible contraceptives
(LARC) and permanent methods, were emphasized in all training
courses for healthcare providers in Bangladesh in view of the recog-
nized value of these interventions in preventing unintended pregnan-
cies and repeat abortions.
Healthcare providers from the following selected hospitals were
trained between 2012 and 2013 and services are now provided at
these institutes. The list includes where the institute is located and its
public or private status:
(1) OGSB Hospital and Institute of Reproductive and Child Health
(IRCH): private.
(2) Institute of Child and Maternal Health (ICMH): autonomous,
peri-urban.
(3) One clinic administered by the Bangladesh Association for the
Prevention of Septic Abortion (BAPSA): NGO, urban slum.
(4) One Marie Stopes clinic: NGO, urban slum and non-slum.
(5) Gazipur District Hospital: government, peripheral.
(6) Gazipur Upazila Hospital: government, peripheral.
(7) Gazipur Maternal and Child Welfare Clinic (MCWC): govern-
ment, peripheral.
5. Results
Two hospitals, the OGSB Hospital and Institute of Reproductive and
Child Health (IRCH) in Mirpur and the Institute of Child and Maternal
Health (ICMH) in Matuail, Dhaka, Bangladesh, where training was initi-
ated in 2012 andwhich receivedMVA equipment andmisoprostol, pro-
vided information on the progress made in the use of the new
technologies promoted to replace D&C and in the provision of postabor-
tion contraception. In the remaining 5 healthcare facilities, it was only
possible to train the service providers in the latter part of 2013. This
was initially due to a general lack of lawandorder in the country around
the time of the elections and later to civil unrest over several political
issues.tion (MVA), and misoprostol for uterine evacuation in the OGSB Hospital and Institute of
th (ICMH), Matuail, Dhaka, Bangladesh.
Misoprostol (%) Total number of cases
ICMH IRCH ICMH IRCH ICMH
0.0 2.0 10.6 51 255
5.5 7.8 11.9 64 201
13.9 13.4 25.5 75 231
Table 2
Trend in postabortion contraceptive acceptance at the OGSB Hospital and Institute of Reproductive and Child Health (IRCH), Mirpur, Bangladesh.
SARCa DMPAb LARCc Permanentd Total number of cases
No. % No. % No. % No. % No. %
January – June, 2012 20 39 24 47 5 10 2 4 51 100.0
July – December, 2012 16 25 25 39 18 28 5 8 64 100.0
January – June, 2013 17 23 31 41 22 29 5 7 75 100.0
a Short-acting reversible contraception (condoms and pills).
b Depot-medroxyprogesterone acetate.
c Long-acting reversible contraceptives (IUD and implants [Implanon]).
d Tubal ligation and vasectomy.
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D&C, MVA, and misoprostol for the treatment of incomplete abortion
between January 2012 and June 2013 showed a clear tendency toward
a reduction in the use of D&C and a corresponding increase in the use
of MVA and misoprostol (Table 1).
In the ﬁrst hospital (the OGSB Hospital and IRCH), D&C was used in
three-quarters of all cases in the ﬁrst half of 2012, but had almost disap-
peared 1 year later. MVA was used in less than a quarter of cases in the
ﬁrst 6 months of 2012, but its use reached 85% in the ﬁrst half of 2013.
The use of misoprostol increased more modestly from 2% to 13% in the
same period (Table 1).
In the ICMH, the changes were less dramatic. Here, the use of D&C
fell from almost 90% between January and June 2012 to 60% in the peri-
od between January and June 2013. MVA use increased from 0% to 14%
and misoprostol from 10% to 25% (Table 1).
Postabortion contraception was adopted by every women admitted
following an abortion at the IRCH. The use of LARC methods almost
tripled, while the adoption of a permanent contraceptive method
almost doubled during the 18-month study period. There was a corre-
sponding reduction in the use of short-acting reversible contracep-
tives (SARC) from almost 40% to less than 25%, with a more modest
reduction in the use of the 3-monthly injectable contraceptive, depot-
medroxyprogesterone acetate (DMPA), which remained the most pop-
ular method, being adopted by 41% of the women in the ﬁnal 6 months
of observation (Table 2).
At the ICMH, the changes were less marked. Acceptance of any
method had already reached 96.8% in the ﬁrst 6 months of observation,
increasing to 99.1% in the second 6 months, and reaching 100% in the
ﬁnal 6 months of observation (data not shown in tables). There was
no change in the use of LARC or permanent methods of contraception
during the study period; however, the use of DMPA increased by almost
10 percentage points, with a corresponding decrease in the use of SARC,
although the latter still remained the preferred method for half of the
women (Table 3).
6. Discussion
In Bangladesh, one of the most important achievements of the FIGO
Initiative for the Prevention of Unsafe Abortion and its Consequences
was raising the awareness of policymakers, managers, clinicians, andTable 3
Trend in postabortion contraceptive acceptance at the Institute of Child and Maternal
Health (ICMH), Matuail, Dhaka, Bangladesh.





No. % No. % No. % No. % No. %
January – June, 2012 148 58.0 72 28.2 14 5.5 13 5.1 255 100.0
July – December, 2012 117 58.2 58 28.9 12 6.0 12 6.0 201 100.0
January – June, 2013 116 50.2 86 37.2 13 5.6 16 7.0 231 100.0
a Short-acting reversible contraception (condoms and pills).
b Depot-medroxyprogesterone acetate.paramedics about unsafe abortion at all levels of healthcare delivery. It
also brought all the stakeholders who provide menstrual regulation
and postabortion care services together under the same umbrella.
The small sample from the two hospitals that provided data follow-
ing training indicates that the shift fromuterine curettage toMVAormi-
soprostol for women with an incomplete abortion is progressing and
that it should be possible to completely replace uterine curettage with
MVA or misoprostol within a relatively short period of time. It also
shows that the goal of increasing the number of women choosing to
use LARCs rather than SARCs following abortion is feasible. The
scaling-up of this small sample to the whole country will be facilitated
by the involvement of government ofﬁcials/managers in this policy
shift. This involvement is evident from the fact that training in MVA
and misoprostol has been incorporated into the operation plan of the
“Health, Nutrition and Population Sector Planning” of Bangladesh.
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